{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:16:16Z","timestamp":1789388176582,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ajp.2022.103007","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T02:41:23Z","timestamp":1642041683000},"page":"103007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project"],"prefix":"10.1016","volume":"69","author":[{"given":"Kayo","family":"Ichihashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Kyou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yasui-Furukori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Takaesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Ohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitoyo","family":"Hishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadasu","family":"Horai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Usami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Makinodan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyokazu","family":"Atake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishiro","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Furihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Inada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoto","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2022.103007_bib1","unstructured":"American Psychiatric Association (APA), 2010. Practice Guideline for the Treatment of Patients With Major Depressive Disorder, third ed. \u3008https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/mdd.pdf\u3009."},{"key":"10.1016\/j.ajp.2022.103007_bib2","series-title":"DSM-5 Diagnostic and Statistical Manual of Mental Health Disorders","author":"American Psychiatric Associstion (APA)","year":"2013"},{"key":"10.1016\/j.ajp.2022.103007_bib3","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (APA), 2021. The American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia, third ed. https:\/\/doi.org\/10.1176\/appi.books.9780890424841.","DOI":"10.1176\/appi.books.9780890424841"},{"issue":"9","key":"10.1016\/j.ajp.2022.103007_bib4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1365-2702.2007.02236.x","article-title":"A best-evidence synthesis review of the administration of psychotropic pro re nata (PRN) medication in in-patient mental health settings","volume":"17","author":"Baker","year":"2008","journal-title":"J. Clin. Nurs."},{"issue":"4","key":"10.1016\/j.ajp.2022.103007_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/09540269609051547","article-title":"The origins of sex differences in depressive disorder: Bridging the gap","volume":"8","author":"Bebbington","year":"1996","journal-title":"Int. Rev. Psychiatry"},{"issue":"7","key":"10.1016\/j.ajp.2022.103007_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1192\/pb.23.7.413","article-title":"Audit: prescription of \u2018as required\u2019 (p.r.n.) medication in an in-patient setting","volume":"23","author":"Bowden","year":"1999","journal-title":"Psychiatr. Bull."},{"issue":"2","key":"10.1016\/j.ajp.2022.103007_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/0269881107067242","article-title":"PRN prescribing in psychiatric inpatients \u2013 potential for pharmacokinetic drug interactions","volume":"21","author":"Davies","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ajp.2022.103007_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.psychres.2016.04.034","article-title":"Socio-demographic and clinical predictors of non-response\/non-remission in treatment resistant depressed patients: a\u00a0systematic review","volume":"240","author":"De Carlo","year":"2016","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.ajp.2022.103007_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2975\/29.2006.215.218","article-title":"Impact of a clinical-administrative review procedure on reducing reliance on psychotropic PRN medication","volume":"29","author":"Donat","year":"2006","journal-title":"Psychiatr. Rehabil. J."},{"issue":"12","key":"10.1016\/j.ajp.2022.103007_bib10","article-title":"\u2018As required\u2019 medication regimens for seriously mentally ill people in hospital","author":"Douglas-Hall","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ajp.2022.103007_bib11","unstructured":"Natinal Institute for Health and Care Excellence (NICE), 2009. Depression in Adults: Recognition and Management. \u3008https:\/\/www.nice.org.uk\/guidance\/cg90\/chapter\/Update-information\u3009."},{"issue":"3","key":"10.1016\/j.ajp.2022.103007_bib12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/S0033291712001511","article-title":"Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature","volume":"43","author":"Ferrari","year":"2013","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.ajp.2022.103007_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/pcn.12056","article-title":"Excessive dosing and polypharmacy of antipsychotics caused by pro re nata in agitated patients with schizophrenia","volume":"67","author":"Fujita","year":"2013","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ajp.2022.103007_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.sleep.2021.11.005","article-title":"Factors associated with hypnotic medication use among inpatients with schizophrenia andmajor depressive disorders: results of a nationwide study","volume":"89","author":"Furihata","year":"2021","journal-title":"Sleep Med."},{"issue":"5","key":"10.1016\/j.ajp.2022.103007_bib15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1440-1614.2002.01069.x","article-title":"Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals","volume":"36","author":"Geffen","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.ajp.2022.103007_bib16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jamapsychiatry.2015.0891","article-title":"Evaluation of antipsychotic dose reduction in late-life schizophrenia a prospective dopamine D-2\/3 receptor occupancy study","volume":"72","author":"Graff-Guerrero","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ajp.2022.103007_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102744","article-title":"Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project","volume":"63","author":"Hashimoto","year":"2021","journal-title":"Asian J. Psychiatry"},{"issue":"5","key":"10.1016\/j.ajp.2022.103007_bib18","article-title":"New generation antidepressants for depression in children and adolescents: a network meta-analysis","author":"Hetrick","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"Suppl E1","key":"10.1016\/j.ajp.2022.103007_bib19","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.9058se1c.05gry","article-title":"Major depressive disorder treatment guidelines in Japan","volume":"71","author":"Higuchi","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2022.103007_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1067\/mem.2001.119456","article-title":"Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department","volume":"38","author":"Hohl","year":"2001","journal-title":"Ann. Emerg. Med."},{"issue":"3","key":"10.1016\/j.ajp.2022.103007_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/npr2.12122","article-title":"Prescription patterns in patients with schizophrenia in Japan: first-quality indicator data from the survey of \u201cEffectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)\u201d project","volume":"40","author":"Ichihashi","year":"2020","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"12","key":"10.1016\/j.ajp.2022.103007_bib22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/pcn.13143","article-title":"Unmet needs of patients with major depressive disorder\u2014findings from the \u2018Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)\u2019 project: a nationwide dissemination, education, and evaluation study","volume":"74","author":"Iida","year":"2020","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ajp.2022.103007_bib23","unstructured":"Iida H., Okada T., Nemoto K., Hasegawa N., Numata S., Ogasawara K., Miura K., Matsumoto J., Hori H., Iga J., Ichihashi K., Hashimoto N., Yamada H., d, Ohi K., Yasui-Furukori N., Fukumoto K., Tsuboi T., Usami M., Furihata R., Takaesu Y., Hishimoto A., Muraoka H., Katsumoto E., Nagasawa T., Ochi S., Komatsu H., Kikuchi S., Takeshima M., Onitsuka T., Tamai S., Kubota C., Inada K., Watanabe K., Kawasaki H., Hashimoto R. , Satisfaction with Web-Based Courses on Clinical Practice Guidelines for Psychiatrists: Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' Project. (in submission)."},{"issue":"8","key":"10.1016\/j.ajp.2022.103007_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ajp.2022.103007_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1192\/bjp.187.3.243","article-title":"Polypharmacy and excessive dosing: psychiatrists\u2019 perceptions of antipsychotic drug prescription","volume":"187","author":"Ito","year":"2005","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103007_bib26","series-title":"Emergency Psychiatriy Guidelines 2015","author":"Japanese Association for Emergency Psychiatry (JAEP)","year":"2015"},{"issue":"3","key":"10.1016\/j.ajp.2022.103007_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/npr2.12193","article-title":"Japanese Society of Neuropsychopharmacology: \u201cGuideline for Pharmacological Therapy of Schizophrenia\u201d","volume":"41","author":"Japanese Society of Neuropsychopharmacology (JSNP)","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.ajp.2022.103007_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjo.2021.982","article-title":"Prescription patterns in psychiatric compulsory care: polypharmacy and high-dose antipsychotics","volume":"7","author":"Kaikoushi","year":"2021","journal-title":"BJPsych Open"},{"issue":"2","key":"10.1016\/j.ajp.2022.103007_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S2215-0366(16)30263-2","article-title":"Why is depression more common among women than among men?","volume":"4","author":"Kuehner","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2022.103007_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/inm.12265","article-title":"Descriptive analysis of pro re nata medication use at a Canadian psychiatric hospital","volume":"26","author":"Martin","year":"2017","journal-title":"Int. J. Ment. Health Nurs."},{"key":"10.1016\/j.ajp.2022.103007_bib31","first-page":"17","article-title":"What is polypharmacy? A systematic review of definitions","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr."},{"issue":"10","key":"10.1016\/j.ajp.2022.103007_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.11124\/JBISRIR-2016-003167","article-title":"Experiences of mental health professionals and patients in the use of pro re nata medication in acute adult mental healthcare settings: a systematic review","volume":"14","author":"Morkunas","year":"2016","journal-title":"JBI Database Syst. Rev. Implement. Rep."},{"issue":"2","key":"10.1016\/j.ajp.2022.103007_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/npr2.12173","article-title":"Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study","volume":"41","author":"Numata","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.ajp.2022.103007_bib34","doi-asserted-by":"crossref","unstructured":"Ogasawara, K., Numata, S., Hasegawa, N., Nakataki, M., Makinodan, M., Ohi, K., Takeshima, M., Tsuboi, T., Hashimoto, N., Onitsuka, T., Muraoka, H., Hori, H., Ichihashi, K., Inagaki, T., Yasui-Furukori, N., Hishimoto, A., Sugiyama, N., Fukumoto, K., Nagasawa, T., Matsumoto, J., Takaesu, Y., Furihata, R., Nemoto, K., Nakamura, T., Usami, M., Miura, K., Fujimoto, M., Tagata, H., Yamada, H., Komatsu, H., Ochi, S., Atake, K., Katsumoto, E., Kido, M., Kishimoto, T., Suwa, T., Yamamura, S., Iga, J., Iida, H., Inada, K., Watanabe, K. & Hashimoto, R., 2021. The subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry. (in submission).","DOI":"10.1002\/npr2.12245"},{"issue":"10","key":"10.1016\/j.ajp.2022.103007_bib35","first-page":"1159","article-title":"Review of the new treatment guideline for major depressive disorder by the Japanese Society of Mood Disorders","volume":"64","author":"Ogasawara","year":"2012","journal-title":"Brain Nerve"},{"issue":"1","key":"10.1016\/j.ajp.2022.103007_bib36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/104012371903100113","article-title":"Evidence for using PRN pharmacotherapy to treat undifferentiated acute agitation or aggression","volume":"31","author":"Patel","year":"2019","journal-title":"Ann. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2022.103007_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1192\/bjp.bp.107.042895","article-title":"High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing","volume":"192","author":"Paton","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103007_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1192\/S0007125000291952","article-title":"Depression in women","volume":"10","author":"Paykel","year":"1991","journal-title":"Br. J. Psychiatry Suppl."},{"issue":"5","key":"10.1016\/j.ajp.2022.103007_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1371\/journal.pmed.0020141","article-title":"A systematic review of the prevalence of schizophrenia","volume":"2","author":"Saha","year":"2005","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.ajp.2022.103007_bib40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/cap.2019.0131","article-title":"Pro Re Nata medication use in acute care adolescent psychiatric unit","volume":"30","author":"Saito","year":"2020","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.ajp.2022.103007_bib41","article-title":"Age-related change in hepatic clearance inferred from multiple population pharmacokinetic studies: comparison with renal clearance and their associations with organ weight and blood flow","author":"Soejima","year":"2021","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.ajp.2022.103007_bib42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/YCO.0000000000000694","article-title":"Ageing with schizophrenia: an update","volume":"34","author":"Solomon","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"issue":"4","key":"10.1016\/j.ajp.2022.103007_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/00048670701881553","article-title":"Use of pro re nata medications in acute inpatient care","volume":"42","author":"Stein-Parbury","year":"2008","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.ajp.2022.103007_bib44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1447-0349.2012.00834.x","article-title":"Behavioural antecedents to pro re nata psychotropic medication administration on acute psychiatric wards","volume":"21","author":"Stewart","year":"2012","journal-title":"Int. J. Ment. Health Nurs."},{"issue":"10","key":"10.1016\/j.ajp.2022.103007_bib45","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/pcn.12911","volume":"73","author":"Takaesu","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"11","key":"10.1016\/j.ajp.2022.103007_bib46","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/pcn.13141","article-title":"Toward co-production of research in 22q11.2 deletion syndrome: research needs from the caregiver\u2019s perspective","volume":"74","author":"Tamune","year":"2020","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.ajp.2022.103007_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.04.011","article-title":"Schizophrenia, \u201cjust the facts\u201d what we know in 2008. 2. Epidemiology and etiology","volume":"102","author":"Tandon","year":"2008","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.ajp.2022.103007_bib48","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.pnpbp.2009.04.023","article-title":"Dosing of antipsychotics in schizophrenia across the life-spectrum","volume":"33","author":"Uchida","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2022.103007_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/pharmacy6030095","article-title":"Patient safety and Pro Re Nata prescription and administration: a systematic review","volume":"6","author":"Vaismoradi","year":"2018","journal-title":"Pharmacy"},{"issue":"3","key":"10.1016\/j.ajp.2022.103007_bib50","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/da.10101","article-title":"Are there gender differences in objective and subjective sleep measures? A study of insomniacs and healthy controls","volume":"17","author":"Voderholzer","year":"2003","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.ajp.2022.103007_bib51","unstructured":"Yamada H., Motoyama M., Hasegawa N., Miura K., Matsumoto J., Ohi K., Yasui-Furukori N., Numata S., Takeshima M., Sugiyama N., Nagasawa T., Kubota C., Atake K., Tsuboi T., Ichihashi K., Hashimoto N., Inagaki T., Takaesu Y., Iga J., Hori H., Onitsuka T., Komatsu H., Hishimoto A., Fukumoto K., Fujimoto M., Nakamura T., Nemoto K., Furihata R., Yamamura S., Yamagata H.K., Katsumoto E., Murata A., Iida H., Ochi S., Makinodan M., Kido M., Kishimoto T., Yasuda Y., Usami M., Suwa T., Inada K., Watanabe K., Hashimoto R. , Improvement of psychiatrists\u2019 clinical behaviors in accordance with the treatment guidelines for schizophrenia and major depressive disorders using the \u2018Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)\u2019 project: nationwide dissemination, education, and evaluation. (in submission)."},{"issue":"00","key":"10.1016\/j.ajp.2022.103007_bib52","first-page":"1","article-title":"Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study","volume":"2021","author":"Yasui-Furukori","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"5","key":"10.1016\/j.ajp.2022.103007_bib53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/YIC.0b013e328362db99","article-title":"Absence of evidence that the pro re nata regimen confers benefit: a review of the studies","volume":"28","author":"Yoshida","year":"2013","journal-title":"Int. Clin. Psychopharmacol."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201822000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201822000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:41:25Z","timestamp":1761756085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201822000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":53,"alternative-id":["S1876201822000053"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2022.103007","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2022.103007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103007"}}